# Paychex Inc: financial statements, quarterly PAYX · Nasdaq · CIK 723531 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31 Pages: [Overview](/companies/payx.md) · [Financials](/companies/payx/financials.md) · [Filings](/companies/payx/filings.md) · [Insiders](/companies/payx/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/payx/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,226](/filings/0000950170-24-138425.md) | [1,395](/filings/0000950170-25-045216.md) | [1,257 d](/filings/0001193125-26-307785.md) | [1,281](/filings/0001193125-25-224997.md) | [1,281](/filings/0001193125-25-328698.md) | [1,466](/filings/0001193125-26-126204.md) | [1,382 d](/filings/0001193125-26-307785.md) | [1,492](/filings/0000723531-26-000006.md) | [1,503](/filings/0001193125-25-328698.md) | [1,752](/filings/0001193125-26-126204.md) | [1,553 d](/filings/0001193125-26-307785.md) | [1,581](/filings/0000723531-26-000006.md) | | Cost of revenue | $m | [364](/filings/0000950170-24-138425.md) | [380](/filings/0000950170-25-045216.md) | [375 d](/filings/0001193125-26-307785.md) | [380](/filings/0001193125-25-224997.md) | [379](/filings/0001193125-25-328698.md) | [387](/filings/0001193125-26-126204.md) | [394 d](/filings/0001193125-26-307785.md) | [414](/filings/0000723531-26-000006.md) | [412](/filings/0001193125-25-328698.md) | [431](/filings/0001193125-26-126204.md) | [417 d](/filings/0001193125-26-307785.md) | [430](/filings/0000723531-26-000006.md) | | Selling, general and administrative | $m | [388](/filings/0000950170-24-138425.md) | [410](/filings/0000950170-25-045216.md) | [438 d](/filings/0001193125-26-307785.md) | [392](/filings/0001193125-25-224997.md) | [400](/filings/0001193125-25-328698.md) | [430](/filings/0001193125-26-126204.md) | [602 d](/filings/0001193125-26-307785.md) | [584](/filings/0000723531-26-000006.md) | [574](/filings/0001193125-25-328698.md) | [586](/filings/0001193125-26-126204.md) | [584 d](/filings/0001193125-26-307785.md) | [581](/filings/0000723531-26-000006.md) | | Operating income | $m | [506](/filings/0000950170-24-138425.md) | [650](/filings/0000950170-25-045216.md) | [482 d](/filings/0001193125-26-307785.md) | [547](/filings/0001193125-25-224997.md) | [538](/filings/0001193125-25-328698.md) | [692](/filings/0001193125-26-126204.md) | [431 d](/filings/0001193125-26-307785.md) | [542](/filings/0000723531-26-000006.md) | [572](/filings/0001193125-25-328698.md) | [792](/filings/0001193125-26-126204.md) | [605 d](/filings/0001193125-26-307785.md) | [619](/filings/0000723531-26-000006.md) | | Interest expense | $m | [8.5](/filings/0000950170-24-138425.md) | [9.9](/filings/0000950170-25-045216.md) | [9.5 d](/filings/0000950170-24-082958.md) | [9.6](/filings/0000950170-24-110834.md) | [9.5](/filings/0000950170-24-138425.md) | [22.6](/filings/0000950170-25-045216.md) | [63.7 d](/filings/0001193125-26-307785.md) | [68.2](/filings/0000723531-26-000006.md) | [68.5](/filings/0001193125-25-328698.md) | [68.1](/filings/0001193125-26-126204.md) | [64.7 d](/filings/0001193125-26-307785.md) | [65.1](/filings/0000723531-26-000006.md) | | Income tax | $m | [125](/filings/0000950170-24-138425.md) | [161](/filings/0000950170-25-045216.md) | [112 d](/filings/0001193125-26-307785.md) | [130](/filings/0001193125-25-224997.md) | [130](/filings/0001193125-25-328698.md) | [167](/filings/0001193125-26-126204.md) | [92.1 d](/filings/0001193125-26-307785.md) | [114](/filings/0000723531-26-000006.md) | [125](/filings/0001193125-25-328698.md) | [179](/filings/0001193125-26-126204.md) | [134 d](/filings/0001193125-26-307785.md) | [135](/filings/0000723531-26-000006.md) | | Net income | $m | [393](/filings/0000950170-24-138425.md) | [499](/filings/0000950170-25-045216.md) | [380 d](/filings/0001193125-26-307785.md) | [427](/filings/0001193125-25-224997.md) | [413](/filings/0001193125-25-328698.md) | [519](/filings/0001193125-26-126204.md) | [297 d](/filings/0001193125-26-307785.md) | [384](/filings/0000723531-26-000006.md) | [395](/filings/0001193125-25-328698.md) | [560](/filings/0001193125-26-126204.md) | [421 d](/filings/0001193125-26-307785.md) | [430](/filings/0000723531-26-000006.md) | | Diluted EPS | $ per share | [1.08](/filings/0000950170-24-138425.md) | [1.38](/filings/0000950170-25-045216.md) | not reported | [1.18](/filings/0001193125-25-224997.md) | [1.14](/filings/0001193125-25-328698.md) | [1.43](/filings/0001193125-26-126204.md) | not reported | [1.06](/filings/0000723531-26-000006.md) | [1.10](/filings/0001193125-25-328698.md) | [1.56](/filings/0001193125-26-126204.md) | not reported | [1.21](/filings/0000723531-26-000006.md) | | Basic EPS | $ per share | [1.09](/filings/0000950170-24-138425.md) | [1.39](/filings/0000950170-25-045216.md) | not reported | [1.19](/filings/0001193125-25-224997.md) | [1.15](/filings/0001193125-25-328698.md) | [1.44](/filings/0001193125-26-126204.md) | not reported | [1.07](/filings/0000723531-26-000006.md) | [1.10](/filings/0001193125-25-328698.md) | [1.56](/filings/0001193125-26-126204.md) | not reported | [1.21](/filings/0000723531-26-000006.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [1.4](/filings/0000950170-24-138425.md) | [1.7](/filings/0000950170-25-045216.md) | [1.5](/filings/0001193125-26-307785.md) | [1.5](/filings/0001193125-25-224997.md) | [1.2](/filings/0001193125-25-328698.md) | [1.6](/filings/0001193125-26-126204.md) | [1.6](/filings/0001193125-26-307785.md) | [0.8](/filings/0000723531-26-000006.md) | [1.5](/filings/0001193125-25-328698.md) | [1.7](/filings/0001193125-26-126204.md) | [1.1](/filings/0000723531-26-000006.md) | [0.6](/filings/0000723531-26-000006.md) | | Current assets | $bn | [8.9](/filings/0000950170-23-072195.md) | [9.9](/filings/0000950170-24-040129.md) | [7.3](/filings/0000950170-25-095300.md) | [7.4](/filings/0000950170-24-110834.md) | [7.4](/filings/0000950170-24-138425.md) | [8.1](/filings/0000950170-25-045216.md) | [8.9](/filings/0001193125-26-307785.md) | [9.0](/filings/0001193125-25-224997.md) | [8.9](/filings/0001193125-25-328698.md) | [9.9](/filings/0001193125-26-126204.md) | [8.6](/filings/0000723531-26-000006.md) | [8.1](/filings/0000723531-26-000006.md) | | Total assets | $bn | [12.1](/filings/0000950170-23-072195.md) | [13.0](/filings/0000950170-24-040129.md) | [10.4](/filings/0000950170-25-095300.md) | [10.5](/filings/0000950170-24-110834.md) | [10.6](/filings/0000950170-24-138425.md) | [11.2](/filings/0000950170-25-045216.md) | [16.6](/filings/0001193125-26-307785.md) | [16.7](/filings/0001193125-25-224997.md) | [16.5](/filings/0001193125-25-328698.md) | [17.5](/filings/0001193125-26-126204.md) | [16.2](/filings/0000723531-26-000006.md) | [15.7](/filings/0000723531-26-000006.md) | | Current liabilities | $bn | [7.3](/filings/0000950170-23-072195.md) | [8.0](/filings/0000950170-24-040129.md) | [5.3](/filings/0000950170-25-095300.md) | [5.3](/filings/0000950170-24-110834.md) | [5.3](/filings/0000950170-24-138425.md) | [5.8](/filings/0000950170-25-045216.md) | [7.0](/filings/0001193125-26-307785.md) | [7.1](/filings/0001193125-25-224997.md) | [7.0](/filings/0001193125-25-328698.md) | [7.9](/filings/0001193125-26-126204.md) | [6.8](/filings/0000723531-26-000006.md) | [6.3](/filings/0000723531-26-000006.md) | | Total liabilities | $bn | [8.5](/filings/0000950170-23-072195.md) | [9.3](/filings/0000950170-24-040129.md) | [6.6](/filings/0000950170-25-095300.md) | [6.6](/filings/0000950170-24-110834.md) | [6.6](/filings/0000950170-24-138425.md) | [7.1](/filings/0000950170-25-045216.md) | [12.4](/filings/0001193125-26-307785.md) | [12.7](/filings/0001193125-25-224997.md) | [12.6](/filings/0001193125-25-328698.md) | [13.5](/filings/0001193125-26-126204.md) | [12.4](/filings/0000723531-26-000006.md) | [12.0](/filings/0000723531-26-000006.md) | | Long-term debt | $bn | [0.8](/filings/0000950170-23-072195.md) | [0.8](/filings/0000950170-24-040129.md) | [0.8](/filings/0000950170-25-095300.md) | [0.8](/filings/0000950170-24-110834.md) | [0.8](/filings/0000950170-24-138425.md) | [0.8](/filings/0000950170-25-045216.md) | [4.5](/filings/0001193125-26-307785.md) | [4.6](/filings/0001193125-25-224997.md) | [4.6](/filings/0001193125-25-328698.md) | [4.6](/filings/0001193125-26-126204.md) | [4.6](/filings/0000723531-26-000006.md) | [4.6](/filings/0000723531-26-000006.md) | | Current portion of debt | $bn | not reported | not reported | [0.0](/filings/0000950170-25-095300.md) | not reported | not reported | not reported | [0.4](/filings/0001193125-26-307785.md) | [0.4](/filings/0001193125-25-224997.md) | [0.4](/filings/0001193125-25-328698.md) | [0.4](/filings/0001193125-26-126204.md) | [0.0](/filings/0001193125-26-307785.md) | not reported | | Short-term borrowings | $bn | [0.0](/filings/0000950170-23-072195.md) | [0.0](/filings/0000950170-24-040129.md) | [0.0](/filings/0000950170-25-095300.md) | [0.0](/filings/0000950170-24-110834.md) | [0.0](/filings/0000950170-24-138425.md) | [0.0](/filings/0000950170-25-045216.md) | [0.0](/filings/0001193125-26-307785.md) | [0.0](/filings/0001193125-25-224997.md) | [0.0](/filings/0001193125-25-328698.md) | [0.0](/filings/0001193125-26-126204.md) | [0.0](/filings/0001193125-26-307785.md) | not reported | | Shareholders' equity | $bn | [3.5](/filings/0000950170-25-045216.md) | [3.7](/filings/0000950170-25-045216.md) | [3.8](/filings/0001193125-26-307785.md) | [3.9](/filings/0001193125-25-328698.md) | [3.9](/filings/0001193125-26-126204.md) | [4.1](/filings/0001193125-26-126204.md) | [4.1](/filings/0000723531-26-000006.md) | [4.0](/filings/0000723531-26-000006.md) | [3.9](/filings/0001193125-26-126204.md) | [4.0](/filings/0001193125-26-126204.md) | [3.7](/filings/0000723531-26-000006.md) | [3.7](/filings/0000723531-26-000006.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [311 d](/filings/0000950170-24-138425.md) | [672 d](/filings/0000950170-25-045216.md) | [222 d](/filings/0001193125-26-307785.md) | [546](/filings/0001193125-25-224997.md) | [295 d](/filings/0001193125-25-328698.md) | [716 d](/filings/0001193125-26-126204.md) | [344 d](/filings/0001193125-26-307785.md) | [718](/filings/0000723531-26-000006.md) | [445 d](/filings/0001193125-25-328698.md) | [813 d](/filings/0001193125-26-126204.md) | [581 d](/filings/0001193125-26-307785.md) | [414](/filings/0000723531-26-000006.md) | | Capital expenditure | $m | [40.7 d](/filings/0000950170-24-138425.md) | [40.7 d](/filings/0000950170-25-045216.md) | [41.3 d](/filings/0001193125-26-307785.md) | [35.6](/filings/0001193125-25-224997.md) | [47.0 d](/filings/0001193125-25-328698.md) | [48.7 d](/filings/0001193125-26-126204.md) | [60.5 d](/filings/0001193125-26-307785.md) | [55.9](/filings/0000723531-26-000006.md) | [62.1 d](/filings/0001193125-25-328698.md) | [51.0 d](/filings/0001193125-26-126204.md) | [65.9 d](/filings/0001193125-26-307785.md) | [56.1](/filings/0000723531-26-000006.md) | | Dividends paid | $m | [320 d](/filings/0000950170-24-138425.md) | [320 d](/filings/0000950170-25-045216.md) | [353 d](/filings/0001193125-26-307785.md) | [353](/filings/0001193125-25-224997.md) | [353 d](/filings/0001193125-25-328698.md) | [353 d](/filings/0001193125-26-126204.md) | [389 d](/filings/0001193125-26-307785.md) | [389](/filings/0000723531-26-000006.md) | [388 d](/filings/0001193125-25-328698.md) | [388 d](/filings/0001193125-26-126204.md) | [425 d](/filings/0001193125-26-307785.md) | [424](/filings/0000723531-26-000006.md) | | Share repurchases | $m | not reported | [0.0 d](/filings/0000950170-25-045216.md) | [0.0 d](/filings/0001193125-26-307785.md) | [104](/filings/0001193125-25-224997.md) | [0.5 d](/filings/0001193125-25-328698.md) | [0.0 d](/filings/0001193125-26-126204.md) | [0.0 d](/filings/0001193125-26-307785.md) | [160](/filings/0000723531-26-000006.md) | [127 d](/filings/0001193125-25-328698.md) | [75.0 d](/filings/0001193125-26-126204.md) | [249 d](/filings/0001193125-26-307785.md) | [0.0](/filings/0000723531-26-000006.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-11-30) | Q3 FY2023 (2023-02-28) | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [362](/filings/0000950170-23-072195.md) | [362](/filings/0000950170-24-040129.md) | [363](/filings/0000950170-24-110834.md) | [362](/filings/0000950170-24-138425.md) | [362](/filings/0000950170-25-045216.md) | [362](/filings/0001193125-25-224997.md) | [362](/filings/0001193125-25-328698.md) | [362](/filings/0001193125-26-126204.md) | [362](/filings/0000723531-26-000006.md) | [360](/filings/0001193125-25-328698.md) | [360](/filings/0001193125-26-126204.md) | [357](/filings/0000723531-26-000006.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 355,980,473 at 2026-08-31, from the cover of the [10-Q filed 2026-09-24](/filings/0000723531-26-000006.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.